36 results
8-K
EVOK
Evoke Pharma Inc
21 Mar 24
Departure of Directors or Certain Officers
4:15pm
statement on Schedule 14A for the 2023 annual meeting of stockholders filed with the SEC on March 29, 2023 under the heading “Executive Compensation
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
of such person who is granted the waiver and the date of the waiver on our website in the future.
Item 11. Executive Compensation
Information required … by this item will be contained in our Definitive Proxy Statement under the heading “Executive Compensation and Other Information” and is incorporated
424B4
vpujkrla hwfv4vj
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
EX-10.2
5trhq8l3yr70bhxz
11 May 23
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.1
mjaj6qzs
11 May 23
Departure of Directors or Certain Officers
4:00pm